Oramed Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -30 | -30 | -31 |
EBITDA | -3,629 | -5,642 | 59,482 |
EBIT | -3,659 | -5,672 | 59,451 |
Net Income | 38,310 | 10,009 | 48,395 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -2,920 | -264 | -1,987 |
Cash | 13,202 | 45,947 | 52,179 |
Basic Shares | 41,970 | 40,452 | 42,774 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,000 | $0 | $1,340 | $2,703 |
Gross Profit | 13 | -193 | 1,340 | 2,703 |
EBITDA | 75,445 | -14,874 | 7,321 | -36,976 |
EBIT | 75,324 | -15,067 | 7,125 | -40,598 |
Net Income | 64,050 | -19,060 | 5,525 | -37,764 |
Net Change In Cash | 2,000 | 0 | 1,340 | 2,703 |
Free Cash Flow | -11,078 | -8,430 | -10,549 | -29,197 |
Cash | 45,947 | 54,420 | 9,055 | 40,464 |
Basic Shares | 42,418 | 40,850 | 40,566 | 38,997 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.09 |
2026-03-31 | $0.91 |
2025-12-31 | $0.25 |
2025-09-30 | $1.13 |